GALA RENEE D — SEC Form 4 filings
SEC reporting owner CIK 1607737. 20 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-01-19 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 2,000 shares, $486,060 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 2,000 shares @ $243.03 ($486,060) in Jazz Pharmaceuticals plc, filed 2026-09-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | President & CEO | 16 | — | 1 leg · 2,000 sh · $486,060 | 20 |
| DEXCOM INC (DXCM) | Director | 4 | — | — | 4 |
Form 4 filings — GALA RENEE D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,967 @ $246.81 · Sale (S): 2,000 @ $243.03 | EDGAR |
| 2026-07-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 4,835 @ $237.72 | EDGAR |
| 2026-06-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Gift (G): 600 @ $0 | EDGAR |
| 2026-06-01 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 5,605 @ $0 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 7,065 @ $188.69 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 44,465 @ $0 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 12,741 @ $0 · Tax withholding (F): 5,371 @ $171.16 | EDGAR |
| 2025-12-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 80 @ $166.91 | EDGAR |
| 2025-08-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 18,808 @ $0 | EDGAR |
| 2025-07-07 | 4/A | DEXCOM INC (DXCM) | Grant/award (A): 1,161 @ $0 | EDGAR |
| 2025-05-12 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 5,074 @ $0 | EDGAR |
| 2025-03-10 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 5,720 @ $0 | EDGAR |
| 2025-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 5,704 @ $138.95 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 23,111 @ $0 · Grant/award (A): 11,555 @ $0 | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 7,741 @ $0 · Tax withholding (F): 3,300 @ $122.62 | EDGAR |
| 2024-12-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 80 @ $123.45 | EDGAR |
| 2024-04-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,736 @ $115.21 | EDGAR |
| 2024-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 3,622 @ $117.53 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 19,916 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 7,079 @ $0 · Tax withholding (F): 3,204 @ $119.13 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1607737 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →